Skip to main content

$0.072 -0.008 (-10.00%)

High

$0.08

Low

$0.07

Trades

9

Turnover

$21,139

Volume

290,277
30 June 2023 at 2:26pm
Register to track BIO and receive email alerts.

Biome Lift Clinical Trial Hits Recruitment Target

StockBot

416,823 posts

BIO released this announcement to the ASX on 1 September 2022, 8:51. The announcement is marked as price sensitive, and is 4 page(s) in length and 210.57kb in size.

You can view all announcements from BIO and see how they appear on a price chart on the announcements page.

At the date of this announcement, BIO was 0.013% short sold according to ASIC data. It was ranked the 577th most shorted stock on the ASX. It is now ranked as the 406th most shorted stock on the ASX with 0.184% of total shares short sold as of the latest reported data (26 May 2026).

Other Recent Announcements from BIO
Biome secures $1.2 million revolving debt facility 28 June 2023, 8:35
Biome surpasses $7m sales revenue target 15 June 2023, 8:31
Correction to Quarterly Activities Report 20 April 2023, 10:07
Biome Lift Clinical Trial Hits Recruitment Target 1 September 2022, 8:51
Delivery of Activated Probiotics to 370 Priceline Pharmacies 31 August 2022, 9:41
Application for quotation of securities - BIO 31 August 2022, 8:56
Release of Restricted Securities from Escrow 30 August 2022, 9:31
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track BIO and receive email alerts.